Tricia Cooney

Dr. Kate Stephenson explores the often-overlooked reality of women’s health—particularly vaginal infections that impact millions each year—and why better solutions are long overdue. She introduces CERN’s innovative device, designed to treat these conditions without the side effects of traditional medications, and breaks down the science behind how it works. The conversation also tackles the cultural stigma that keeps these issues in the shadows, the regulatory hurdles of bringing new medical technologies to market, and the importance of building strong networks to advance women’s health innovation. Kate shares her journey as a female engineer and entrepreneur in a male-dominated field, offering insight into resilience, leadership, and the need for more diverse, patient-centered solutions. Chapters: 00:00 The Unspoken Health Crisis for Women 03:00 Innovative Solutions in Women's Health 06:06 Breaking the Silence: Cultural Barriers in Women's Health 08:56 The Science Behind the CERN Device 11:56 Navigating Regulatory Challenges 14:52 The Journey of a Female Engineer in MedTech 17:50 Building a Network for Change 22:47 Navigating Women's Health in Tech 28:53 Overcoming Challenges as a Woman in Engineering 36:40 The Journey of Entrepreneurship and Consulting 41:36 Building Connections in the Bullpen Network 45:58 Future Directions for CERN and Personal Growth Guest Information:Guest's Name:  Dr. Kate StephensonGuest's Title/Position: VP EngineeringGuest's Linkedin: https://www.linkedin.com/in/dyadengineering/Company / Affiliation: CERN Device https://cerndevice.com/Guest's Bio: Dr. Stephenson is a Stanford Engineering PhD with a deep technical consulting background in the design and development of products at life science startups. She has a twenty-year history of strategic early-stage technical projects in a wide range of novel medical products, including medical device, digital health, drug delivery and pharma. A long-term resident of California’s Silicon Valley, her active network spans the life sciences community, including R1 academic centers, major strategics, investors, and startups. Her three key areas of expertise include evaluation of regulated medical products, entrepreneurship education and technical writing. Takeaways:30 million women visit doctors for vaginal infections annually.Vaginal infections are the second leading cause for women in the ER.Current treatments for vaginal infections have not evolved in 40 years.CERN Corporation is developing a device to treat vaginal infections using microbicidal light.Cultural stigma prevents women from discussing their health issues.Women often receive incorrect diagnoses for vaginal infections.The CERN device is designed for home use with no drugs involved.The device uses blue light to target specific pathogens safely.Regulatory challenges exist in bringing innovative women's health devices to market.Networking and education are crucial for advancing women's health initiatives. I am calling the shots and organizing the engineering teams.The end result is helping women get over these health issues.We need to come up not with just one solution, but with a dozen options.The ultimate intent of this product is it's a home use product.The doctors hate it because literally it is the bare bottom value they offer.I joined the boys wrestling team my senior year to support a friend.I realized I had gone through four years of engineering education without a female professor.I want other women engineers to experience being taught by a woman.I'm the kid whose friend got bullied and I took action.I appreciate going to some of these events for networking. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

In this episode of the Helping Enterprise podcast, host Heath Fletcher speaks with Larry Chism, a seasoned talent acquisition executive, about the evolving landscape of recruitment. They discuss the impact of technology, particularly AI, on hiring processes, the importance of human connection in recruitment, and the challenges faced by both job seekers and employers in today's market. Larry shares insights on bridging the gap between retiring professionals and new graduates, as well as the unique challenges within the healthcare sector. The conversation emphasizes the need for adaptability, networking, and maintaining a positive outlook in the face of change. Chapters: 00:00 Introduction to Talent Acquisition and Larry Chism 04:03 The Evolution of Recruitment: Challenges and Opportunities 09:09 The Role of AI in Recruitment 15:14 Headhunting vs. Passive Recruitment 18:34 Bridging the Gap: Workforce Attrition and New Graduates 30:48 Challenges in the Healthcare Recruitment Landscape 35:21 Quality of Life and the Future of Work Guest Information:Guest's Name:  Larry L. ChismGuest's Title/Position:  Chief Executive Officer Guest's Linkedin: https://www.linkedin.com/in/larrylchism/Company / Affiliation:  Quantus Management Resources https://www.qmrconsultants.com/Guest's Bio:  Larry L. Chism is a Senior Talent Acquisition Executive and entrepreneur with 25+ years of experience in full-cycle recruiting and strategic growth talent solutions. Throughout his career, Larry has placed hundreds of high-impact professionals—from junior contributors to C-suite leaders—across startups, Fortune 100 companies, and the biopharmaceutical and life sciences sectors. Notably, he has served in talent acquisition leadership roles supporting biopharma organizations, including Talent Acquisition at Rentschler Biopharma, where he focused on sourcing exceptional scientific, technical, and commercial talent in a highly competitive market. Takeaways:Larry Chism has over 25 years of experience in recruitment.AI is significantly changing how resumes are screened.Headhunting is becoming more essential for higher-level positions.There is a notable gap between retiring professionals and new graduates.Quality of life considerations are increasingly important for job seekers.Networking and mentorship are crucial for career advancement.Internships provide valuable experience for new graduates.The reliance on technology can create challenges in recruitment.Maintaining a positive attitude is essential for job seekers.Adaptability is key in the evolving job market. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

In this episode of The Healthy Enterprise, Dr. Psyche Young, a licensed professional counselor and trauma-informed therapist, shares her path into mental health and the values that guide her work. She explores the importance of transparency in therapy, work-life balance, and an integrative model of care that honors the mind-body-spirit connection. Dr. Young also unpacks the realities of modern mental health care — from insurance challenges and the rise of telehealth to the growing role of technology and psychoeducation in prevention. The conversation offers thoughtful insight and practical advice for both clients and aspiring therapists navigating today’s mental health landscape. Chapters: 00:00 Introduction to Dr. Psyche Young 02:24 Journey into Mental Health 03:36 Specializations in Therapy 05:03 Balancing Life and Business 06:10 Understanding Stress and Work-Life Balance 09:02 The Importance of Transparency in Therapy 10:30 Core Values and Purpose 14:11 Integrative Care in Mental Health 17:12 Mind-Body-Spirit Connection 19:22 Building Therapeutic Relationships 21:45 The Ripple Effect of Therapy 23:05 Navigating Insurance and Payment Disparities 24:10 The Role of Technology in Therapy 25:24 The Human Element in Telehealth 28:41 Expanding Reach Through Speaking Engagements 33:05 Supporting Healthcare Professionals 36:50 The Importance of Psychoeducation 39:28 Future Projects and Growth 40:41 Advice for Aspiring Therapists Guest Information:Guest's Name: Dr. Psyche YoungGuest's Title/Position:  Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/psyche-young-ph-d-lpc-%F0%9F%87%B0%F0%9F%87%B3%F0%9F%87%A6%F0%9F%87%AE-82136a14/Company / Affiliation: YaH Vision Counseling & Wellness   https://www.yahvisioncw.com  |  https://www.instagram.com/yahvisioncounseling/  |  https://www.facebook.com/people/YaH-Vision-Counseling-Wellness/61556108247813/Guest's Bio: Psyche Young, Ph.D., LPC is a licensed psychotherapist, consultant, and public speaker with over a decade of clinical experience supporting individuals, couples, and families. She is the Owner and CEO of YaH Vision Counseling & Wellness LLC and Co-Founder of YaH Vision Productions, with a particular focus on marriage and family therapy and working with military families navigating complex life transitions. A recognized thought leader in mental health, Dr. Young empowers clients to overcome barriers to personal and professional growth while building emotional resilience and sustainable wellness strategies. She is an engaging speaker and trusted consultant known for blending clinical expertise with real-world application. Dr. Young is a member of the American Association for Marriage and Family Therapy (AAMFT) and the American Counseling Association (ACA) and is guided by a core belief that wellness is not a privilege — it’s a human right. Takeaways:Dr. Psyche Young has over 20 years of experience in mental health.She specializes in marriage and family therapy, particularly with military families.Work-life balance is crucial for mental health and well-being.Stress often indicates a lack of balance in life.Transparency in therapy is essential for effective treatment.Core values play a significant role in personal fulfillment.Mental health is interconnected with physical and social health.Integrative care models are becoming more common in healthcare.Building rapport with clients is vital for therapeutic success.The ripple effect of therapy can lead to healthier families and communities. Insurance disparities affect access to mental health care.Telehealth offers convenience but lacks the human touch.Healthcare professionals are increasingly prioritizing their mental health.Psychoeducation is vital for understanding mental health experiences.Proactive approaches are better than reactive ones in mental health care.The body’s chemical responses play a role in mental health.Networking is essential for growth in the mental health field.Support is available for those seeking help.Self-care is crucial for healthcare providers.Future projects can enhance community support and outreach. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

In this episode, Adityo Prakash, founder and CEO of Verseon, shares how his company is transforming drug discovery through deep quantum modeling and advanced computational science. He discusses the challenges of traditional drug development, the limitations of current AI approaches, and how Verseon’s technology is redefining how we tackle complex diseases like diabetes and cancer. Adityo also reflects on the company’s mission-driven culture, its focus on addressing root causes rather than symptoms, and the importance of building a scientific community to accelerate truly transformative medicine. Chapters: 00:00 Introduction to Verseon and Adityo Prakash 03:07 The Journey of Drug Discovery and Innovation 06:03 Challenges in Current Drug Development Models 08:57 The Role of AI in Drug Discovery 11:58 Deep Quantum Modeling: A New Frontier 15:11 Transforming Drug Development Processes 18:07 Real-World Applications and Success Stories 27:13 Innovations in Diabetes Treatment 30:03 Advancements in Cancer Therapies 32:09 The Vision Behind the Company 35:02 Navigating Challenges in Drug Development 35:58 The Role of Quantum Computing in Drug Discovery 38:49 Choosing Disease Targets for Drug Development 42:59 Leadership Evolution and Company Culture 45:46 Attracting Investors and Building Community Guest Information:Guest's Name: Adityo PrakashGuest's Linkedin: https://www.linkedin.com/in/adityo-prakash-3a5b928/ Company / Affiliation: Verseon https://www.verseon.com/Guest's Bio: Adityo Prakash is a scientist-entrepreneur and the Founder & CEO of Verseon, where he is transforming drug discovery and development through Deep Quantum Modeling and AI. Driven by the belief that current methods limit the medicines the world can create, he built Verseon to systematically design therapeutics previously out of reach and elevate the standard of care across major diseases. Before Verseon, he founded Pulsent Corporation, developing foundational technologies that power modern video streaming. His work across physics, computation, and engineering has produced more than 40 patent families, and he holds a BS in Physics and Mathematics from Caltech. Takeaways:Verseon aims to redefine drug discovery through AI and quantum modeling.The journey of drug discovery has been long and challenging.Current drug development models are outdated and inefficient.AI's role in drug discovery is often limited to existing data.Deep quantum modeling offers a new approach to drug design.The pharmaceutical industry faces dismal odds in drug development.Innovative drugs can change treatment paradigms for major diseases.Real-world applications of new drugs show promising results.The need for systematic approaches in drug discovery is critical.Verseon's mission is to create new medicines for previously untreatable diseases. The shift from monthly to bi-monthly injections for diabetes treatment is still inadequate.Current diabetes treatments often fail to address root causes, focusing instead on symptoms.Innovative drugs can reverse diabetes in early stages with oral administration.The company is developing multiple cancer therapies that target metastasis and immune response.New chemotherapy agents are being created to remain effective even as tumors mutate.The founders aimed to revolutionize drug discovery to better treat diseases.External factors like economic downturns can significantly impact drug development timelines.The integration of quantum computing is crucial for simulating complex biological systems.Choosing disease targets is based on large unmet medical needs and well-understood biology.Leadership involves continuous learning and adapting to foster a culture of innovation. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

In this milestone 50th episode of The Healthy Enterprise, Bullzeye CEO Meghna Deshraj shares the personal journey behind building a business rooted in intention, resilience, and alignment. From leaving a stable corporate path to becoming an entrepreneur, angel investor, and global growth strategist, Meghna reflects on how marketing, healthcare, and human-centered partnership have shaped her leadership. She explains why real growth isn’t driven by louder campaigns, but by clarity, adaptation, and staying close to the people you serve. Her story captures what it truly means to be a modern growth partner—walking shoulder to shoulder with founders, helping them navigate complexity, and championing bold, meaningful progress, especially for women in business. Chapters: 00:00 Celebrating Milestones: The 50th Episode 02:05 Meghna's Journey: From Corporate to Entrepreneur 05:47 The Evolution of Marketing: A Unique Approach 12:00 Healthcare: A Personal Connection and Professional Focus 18:06 Global Growth: Expanding Bullzeye's Reach 24:01 The Healthy Enterprise Podcast: Bridging Gaps in Healthcare 30:07 Investing in the Future: Meghna's Role as an Angel Investor 35:48 Overcoming Challenges: The Power of Adaptation 41:59 Final Thoughts: Embracing Change and Growth Guest Information:Guest's Name: Meghna Deshraj Guest's Title/Position:  Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/meghna-deshraj/Company / Affiliation: Bullzeye Global Growth Partners  https://bullzeyeglobal.com/Guest's Bio:  Meghna Deshraj is the Founder & CEO of Bullzeye Global Growth Partners, a strategic consultancy that helps businesses scale sustainably and profitably. With a background spanning corporate strategy, IT, finance, and process optimization, she combines analytical rigor with creative execution to drive measurable results. Under her leadership, Bullzeye has generated over $580M in annual growth and more than $1B in client revenue, guiding organizations through large-scale integrations, business transformations, and organizational change initiatives. A Certified Six Sigma Black Belt, Meghna’s superpower lies in strategic marketing and growth consulting, helping businesses grow through innovation, efficiency, and strong, trusted partnerships. Takeaways: -Meghna Deshraj is the CEO and founder of Bullzeye Global Growth Partners. -She transitioned from a corporate career to entrepreneurship through her passion for marketing. -Marketing is essential for every business, regardless of product quality. -A unique approach to marketing involves understanding client goals and needs. -Healthcare is a personal passion for Meghna, influenced by her family's background. -Global growth for Bullzeye was driven by client demand in international markets. -The Healthy Enterprise Podcast aims to bridge gaps in healthcare knowledge. -Meghna has been an angel investor for over 15 years, focusing on healthcare innovations. -Adapting and evolving are crucial for overcoming challenges in business. -Women should take bold steps and not let setbacks hold them back. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

In this episode of The Healthy Enterprise, Bret Larsen — serial entrepreneur and CEO of Chief — shares his journey from launching his first startup in college to leading multiple high-growth B2B software companies, including the telemedicine platform E-Visit. He reflects on the lessons learned from scaling businesses, navigating the challenges of the pandemic, and transitioning from founder to CEO. Bret discusses the vision behind Chief, a predictive operations platform designed to empower sales leaders, and offers candid insights on mentorship, resilience, and the personal side of entrepreneurship. Chapters: 00:00 Introduction to Brett Larson and His Journey 03:03 The Birth of E-Visit and Telemedicine Innovations 06:00 The Launch of Chief: A Predictive Operations Platform 08:54 The Entrepreneurial Drive: Origins and Influences 11:50 Navigating Challenges in Healthcare Innovation 15:00 Growth During the Pandemic: A Turning Point 18:09 Managing Rapid Growth and New Responsibilities 20:51 Personal Growth and Leadership Development 24:12 The Importance of Mentorship and Skill Evolution 30:47 Unlocking Growth: The Role of Founders' Personal Lives 35:50 Navigating Identity: The Founder vs. CEO Dilemma 41:34 The Evolution of Chief: From Vision to Execution 46:50 Building Chief: Insights from Market Research 52:47 The Unique Value Proposition of Chief 56:38 Passion and Pain: The Reality of Building Businesses Guest Information:Guest's Name:Bret Larsen Guest's Title/Position:   Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/bretalarsen/Company / Affiliation: Chief  https://www.getchief.com/Guest's Bio: Bret Larsen is the Founder and CEO of Chief, a sales performance management platform built to help modern sales teams turn complexity into clarity and make growth inevitable. A 3x founder and seasoned CEO, Bret has built multiple high-growth B2B software companies recognized by Inc. 5000, Deloitte Fast 500, Forrester, and Gartner. Named a Titan 100 CEO, Top 50 CEO in Healthcare Technology, and Ernst & Young Entrepreneur of the Year finalist, he’s known for building high-performing teams and market-defining products. Backed by investors including Goldman Sachs and Kickstart Seed Fund, Bret also advises startups and serves on boards across technology, healthcare, and education. Takeaways:Brett Larson is a three-time founder and CEO with a strong background in B2B software.His first company was a small e-commerce business started during his undergraduate studies.Brett's journey in healthcare began with E-Visit, a telemedicine platform that gained traction during the pandemic.The idea for Chief, his latest venture, was inspired by the need for predictive operations in businesses.Brett's entrepreneurial drive is influenced by his family background and early experiences in business.Healthcare is often slow to adopt technology due to the risks involved, but there are opportunities for innovation.The pandemic created a significant growth opportunity for E-Visit, leading to a 1200% increase in team size.Navigating rapid growth requires a shift in leadership skills and adaptability.Brett highlights the importance of mentorship and executive coaching in his development as a leader.The role of a CEO can be lonely, and perception plays a crucial role in leadership. You cannot increase burn for six months post-investment without proving ROI.Founders' personal lives significantly impact business success.Hiring talented individuals can be intimidating but is essential for growth.Articulating a clear vision is crucial for leadership.Goldman Sachs provides unparalleled support for startups.Recognizing feelings of languishing can lead to renewed purpose.Unlocking operational data is key to business success.The ideal customer for Chief is a VP of Sales or CRO.Pain tolerance is directly correlated to impact in business.Passion for the problem drives resilience in entrepreneurship.

In this episode, Dr. Marsha Hartman, Fractional CEO of Exodigm Biosciences, shares her journey from epidemiology to leading-edge biotech innovation. She explores how Exodigm’s breakthrough cell analysis technology is advancing personalized medicine and reshaping the future of diagnostics. The conversation dives into the lessons learned from COVID-19, the balance between science and strategy in leadership, and the ethical dimensions of AI in healthcare. Dr. Hartman also reflects on the importance of listening, collaboration, and purpose-driven work in creating meaningful impact across the life sciences. Chapters: 00:00 Introduction to Marsha Hartman and Her Journey 03:09 The Intersection of Epidemiology and Immunology 06:00 Sales and Science: A Unique Blend 09:13 COVID-19: A Case Study in Epidemiology and Immunology 11:52 The Role of Biomarkers in Personalized Medicine 15:02 Exodigm: Transforming Cell Analysis 17:58 Marsha's Transition to CEO 20:48 Leadership Philosophy and Personal Growth 27:27 The Art of Listening in Leadership 30:07 Lessons from COVID-19: A Global Experience 34:01 The Role of Technology in Healthcare 36:12 The Future of Personalized Medicine 39:22 Patient Data Ownership and Accessibility 42:20 The Ethical Use of AI in Healthcare 44:23 Finding Your Purpose and Aligning with Others Guest Information:Guest's Name: Dr. Marsha L. HartmanGuest's Title/Position:  Fractional CEOGuest's Linkedin: https://www.linkedin.com/in/marsha-l-hartman-phd-4b77903b/Company / Affiliation:  Exodigm Biosciences https://www.exodigm.com/Guest's Bio: Dr. Marsha L. Hartman is the Fractional CEO of Exodigm Biosciences, a pioneering startup within the General Inception portfolio. At Exodigm, she is leading efforts to revolutionize cellular biology by enabling live single-cell analysis through transcriptomic insights — helping researchers and biomanufacturers work precisely with the cells they need. With a background in epidemiology and extensive leadership experience across diagnostics, biotech, and commercialization, Dr. Hartman brings a strategic and scientific lens to building scalable solutions for the next generation of cell therapy and analysis. Under her leadership, Exodigm is pushing the boundaries of innovation to accelerate discovery and redefine what’s possible in cellular science.Takeaways:Marsha Hartman has a unique background in epidemiology and immunology.She transitioned from academia to sales and marketing in the life sciences.COVID-19 highlighted the importance of understanding immunology and epidemiology together.Biomarkers play a crucial role in personalized medicine and treatment outcomes.Exodime is pioneering live cell RNA analysis, which could revolutionize cell therapy.Marsha's leadership style is collaborative and focused on team success.She believes in the power of hard work, honesty, and hope in both life and science.Perfectionism can hinder authentic leadership and team dynamics.Building relationships is key to successful collaboration in science and business.Marsha's journey illustrates the importance of adaptability and continuous learning. As a leader, you must be a philosopher and a listener.Listening to your team can reveal insights you may not be aware of.COVID-19 taught us valuable lessons about collective experiences.Technology has accelerated advancements in healthcare.Personalized medicine is the future of healthcare.Patients should have ownership of their health data.AI can help eliminate biases in data interpretation.Collaboration is key to solving healthcare challenges.Understanding your purpose can guide your actions.Aligning with others can lead to greater impact.

In this episode of The Healthy Enterprise, Dr. Tia Warrick, CEO of Lesous Consulting, shares her journey in clinical research and healthcare education. She discusses the industry gaps that inspired her to launch Lesous, a company focused on bridging those divides through training, mentorship, and innovative technology. Dr. Warrick highlights the importance of practical, accessible education, the growing role of AI in clinical efficiency, and the need for equitable participation in clinical trials. With a passion for teaching and empowerment, she offers valuable insights on leadership, career growth, and creating supportive pathways for the next generation of healthcare professionals. Chapters: 00:00 Introduction to Dr. Tia Warrick and Lesous Consulting 03:03 Dr. Warwick's Journey in Clinical Research 05:51 Identifying Gaps in Clinical Research 08:59 The Role of Education and Training 11:53 Leveraging AI in Clinical Research 14:51 Creating Equity in Clinical Trials 17:48 Innovative Training Solutions 20:56 The Importance of Practical Application in Training 24:11 Challenges and Rewards in Clinical Research 26:51 Bridging the Gap in Healthcare Education 27:16 The Journey to Teaching and Mentorship 29:34 The Impact of Clinical Research 30:54 Transforming Professional Development 34:39 Creating a Safe Learning Environment 36:37 Navigating Career Transitions 39:16 Finding Your True Path 43:00 Overcoming Industry Challenges 48:22 Connecting with Dr. Tia Warrick Guest Information:Guest's Name:  Dr. Tia WarrickGuest's Title/Position:  Chief Executive Officer Guest's Linkedin: https://www.linkedin.com/in/drwarrick/Company / Affiliation: Lesous Consulting https://lesousconsulting.com/Guest's Bio: Dr. Tia Warrick is the CEO of Lesous Consulting, a professional development, training, and technology solutions firm advancing excellence in clinical research and healthcare education. A Certified Global Project Manager with over seven years of experience in the industry, she brings expertise in strategic business analytics, AI software development, e-learning design, epidemiology (including RWE/HEOR), clinical data management, and public health consulting. An award-winning author of “Burst the Bubble: A Look into Careers in the Pharmaceutical Industry,” Dr. Warrick earned her Doctor of Health Science in Clinical Health Education from the University of Bridgeport. With a background in epidemiology and global clinical trials, she is dedicated to bridging gaps across healthcare, research, and education—mentoring the next generation of professionals and driving innovation that promotes equity, collaboration, and impact. TakeawaysDr. Tia Warwick is the CEO of Lesous Consulting, focusing on bridging gaps in clinical research.80% of clinical trials fail due to inefficiencies and administrative bottlenecks.Education and training are crucial for improving clinical research outcomes.AI can enhance efficiency in clinical research without replacing jobs.Creating equity in clinical trials is essential for patient access to treatments.Practical application in training is more valuable than theoretical knowledge.Burnout among clinical research professionals is a significant issue.Innovative training solutions can accelerate experience and reduce mistakes.Collaboration between institutions is key to successful clinical trials.The cost of clinical trials impacts the affordability of treatments for consumers. Dr. Warrick emphasizes the need for equitable healthcare education.Teaching has always been a passion for Dr. Warrick.Clinical research plays a crucial role in patient care.Transforming professional development can lead to industry improvements.Creating a safe learning environment fosters growth.Career transitions require careful navigation and support.Finding one's true path is essential for fulfillment.Overcoming industry challenges involves positivity and resilience.A holistic approach to career coaching considers all aspects of life.Building connections and community is vital for professional success.

In this episode of The Healthy Enterprise, host Michael Gorton shares his journey as a serial entrepreneur and pioneer in telemedicine through his work with Teladoc. He reflects on how COVID-19 accelerated virtual care adoption and introduces his new venture, Recuro, focused on early detection and prevention. The conversation explores innovations in mobile healthcare, AI-driven personal health data, and the future of diagnostics—while touching on the entrepreneurial mindset needed to overcome healthcare’s bureaucratic challenges and drive meaningful change. Chapters: 00:00 Introduction to Michael Gorton and Telemedicine 04:14 The Birth of Teladoc 08:48 Telemedicine's Rise During COVID-19 15:32 Transitioning to Recuro: A New Venture 22:46 Innovations in Early Detection and Prevention 28:28 Innovations in Mobile Healthcare 31:08 The Future of Personal Health Data 34:57 The Role of AI in Early Diagnosis 35:41 The Journey of an Author 39:10 Exploring the Universe: Plasma Physics and Beyond 44:20 Phantom Space: The Future of Data Centers 51:17 Overcoming Bureaucratic Hurdles in Healthcare Guest Information:Guest's Name: Michael GortonGuest's Title/Position:  FounderGuest's Linkedin: https://www.linkedin.com/in/michael-s-gorton/Company / Affiliation: Dynamic Works Consulting https://michaelgorton.us/Guest's Bio: Michael Gorton is a 15-time entrepreneur, author, and pioneer in telemedicine and digital health. As the founder of Teladoc—the world’s largest telemedicine company—he helped ignite a half-trillion-dollar industry. With degrees in engineering and law, Michael has built a career turning bold ideas into reality through ventures spanning healthcare, energy, and technology. A bestselling author and frequent keynote speaker, he continues to inspire innovation and leadership through his writing, public speaking, and mentorship of emerging entrepreneurs.Takeaways:Michael Gorton is a serial entrepreneur and founder of Teladoc.Telemedicine gained significant traction during the COVID-19 pandemic.87% of the U.S. population now prefers telemedicine for consultations.Telemedicine can be more profitable for doctors compared to traditional practices.Early detection in healthcare can prevent costly and dangerous conditions.Recuro aims to simplify healthcare and enhance early detection.The healthcare system is complicated and needs simplification.Innovative technologies can aid in early diagnosis and prevention.Access to healthcare is crucial for rural populations.Making healthcare simple can save lives and reduce costs. Mobile healthcare units are being developed for remote areas.Smartwatches can collect valuable health data.AI can help diagnose health issues early.Personal health data ownership is crucial for patients.Bureaucratic hurdles slow down healthcare innovation.Persistence is key to overcoming challenges in healthcare.Science fiction can inspire real-world innovations.Plasma physics may hold answers to extraterrestrial intelligence.Data centers in space could revolutionize AI processing.Collaboration among innovators is essential for progress.

In this episode of The Healthy Enterprise, Heath sits down with Michele Hart, Director of Marketing Communications at BostonSight, to explore the art and impact of nonprofit marketing in healthcare. Michele shares her journey from anthropology and journalism to leading marketing for a pioneering organization improving lives through innovative scleral lens technology. She discusses the challenges of mission-driven marketing—balancing purpose with growth, navigating the pandemic’s disruption, and aligning teams across marketing, sales, and product development—while emphasizing the importance of clear communication, the value of outsourcing for fresh perspectives, and the strategies that have helped BostonSight strengthen its brand and expand its global reach. Chapters: 00:00 Introduction to Michele Hart and Her Journey 02:52 Transitioning to Nonprofit Marketing 05:54 The Impact of COVID-19 on Work Dynamics 08:55 Understanding BostonSight and Its Mission 11:50 The Science Behind Scleral Lenses 14:59 Marketing Challenges and Strategies at BostonSight 17:52 Navigating the Commercial Landscape of Scleral Lenses 21:01 Expanding Global Reach and Partnerships 23:58 Optimizing Marketing Channels and Strategies 26:23 Streamlining Communication in Marketing 30:31 The Importance of Outsourcing for Fresh Perspectives 34:40 Aligning Marketing, Sales, and Product Development 36:53 Revenue Generation in Nonprofits 38:40 Innovative Marketing Strategies and Patient Engagement 42:25 The Future of Marketing: Balancing Digital and In-Person 45:45 Innovations in Scleral Lens Technology Guest Information:Guest's Name: Michele HartGuest's Title/Position:  Director, Marketing and Communications Guest's Linkedin: https://www.linkedin.com/in/michelespilberghart/Company / Affiliation:BostonSight https://www.bostonsight.org/Guest's Bio: Michele Hart is a strategic and creative communications leader with a proven ability to align business goals with marketing strategy and optimize resources for maximum impact. With extensive experience in the nonprofit and healthcare sectors, she develops high-performing campaigns that engage both B2B and B2C audiences, drive growth, and expand access to meaningful solutions. Her work has been featured in leading outlets including The New York Times, The Boston Globe, Good Housekeeping, TIME, and Prevention Magazine.Takeaways:Michele Hart has over 25 years of experience in healthcare marketing.Her background in anthropology has been valuable in understanding consumer behavior.Transitioning to nonprofit work has provided her with meaningful mission-based experiences.COVID-19 created unique challenges but also fostered team bonding.BostonSight specializes in scleral lenses that improve vision and comfort for patients.The organization has a strong focus on patient care and research.Marketing strategies include optimizing channels and building brand identity.The commercial scleral lens is used by optometrists worldwide.Partnerships with international eye institutes have expanded their reach.Press releases remain a vital tool for internal communication and marketing. Streamlining communication is essential to avoid muddled messaging.Outsourcing can provide valuable insights and an objective perspective.Aligning marketing, sales, and product development is crucial for success.Nonprofits must focus on revenue generation to sustain their mission.Innovative marketing strategies can enhance patient engagement.In-person connections are becoming increasingly important post-pandemic.Traditional marketing methods are seeing a resurgence in the digital age.Scleral lenses are evolving with new technology for better patient outcomes.A focus on prevention in healthcare could transform patient care.Engaging with patients through webinars and testimonials builds trust. 

In this episode of The Healthy Enterprise, Trace Voshell, Chief Revenue Officer at GoGoMeds, shares his journey from baseball player to pharmacy leadership. He discusses the challenges of healthcare costs, innovations in medication access, telemedicine, and custom pharmacy solutions, while offering insights on leadership, team collaboration, and making medications more affordable for employers and employees. Chapters: 00:00 Introduction to GoGoMeds and Trace's Journey 02:57 Understanding Pharmacy Operations and Patient Care 05:54 The Challenges of Healthcare Costs 09:02 Innovations in Medication Access and Employer Benefits 11:52 Telemedicine and Custom Pharmacy Solutions 14:49 Transitioning to GoGoMeds and Leadership Style 24:03 The Drive to Win: A Personal Philosophy 25:04 Documentary Insights: Uncovering Healthcare Costs 28:07 Marketing Strategies: Outsourcing for Growth 32:18 Sales Team Dynamics: Growth and Strategy 34:32 The Balance of Aggression and Patience in Sales 38:03 Building a Winning Corporate Culture 43:13 AI in Business: Balancing Automation and Personal Touch 45:13 Final Thoughts and Future Connections Guest Information:Guest's Name:Trace VoshellGuest's Title/Position: Chief Revenue OfficerGuest's Linkedin: https://www.linkedin.com/in/trace-voshell-34040b7a/Company / Affiliation: GoGoMeds https://gogomeds.com/GoGoClient/homeGuest's Bio: Trace Voshell is the Chief Revenue Officer of GoGoMeds, a company transforming pharmacy pricing by moving beyond traditional PBM models. After a decade in a large PBM-owned pharmacy, Trace shifted to the cash-pay side to make medications more affordable through a transparent, cost-plus pricing model. GoGoMeds empowers employers, physicians, and digital health companies to deliver medicine fairly, save money, and put patients first. Takeaways:Trace Voshell transitioned from a baseball career to pharmacy.GoGoMeds aims to transform patient access to medications.Healthcare costs can be overwhelming for patients.GoGoMeds offers significant savings on generic medications.Employers can benefit from offering $0 medications to employees.Telemedicine is a growing area for GoGoMeds.Custom pharmacy solutions enhance patient care.Trace's personal experience with cancer informs his work.Leadership involves being hands-on and empathetic.Failures are part of the journey to success.  I like to win, don't care about recognition.The documentary 'It's Not Personal, It's Just Healthcare' uncovers hidden costs.Go Go Meds is a solution in the pharmacy space.I was one of the producers of the documentary.We needed to enhance our marketing efforts.You can't just have one marketing piece for all verticals.Aggression and patience are key in sales.Culture is crucial for employee motivation.You have to remain a person in sales interactions.We're changing the pharmacy landscape for affordability.

In this episode of The Healthy Enterprise, host Brian Newsom discusses his journey in the biotechnology field, focusing on his role as CEO of Carrigent, a company specializing in cell and gene therapy. He elaborates on the innovative vector technology being developed for targeted payload delivery, the challenges of fundraising in the current market, and the integration of AI to enhance operational efficiency. Brian also shares insights into the importance of strategic partnerships and the ultimate goal of bringing therapeutic solutions to patients. In this conversation, the speaker discusses the importance of building long-term relationships in healthcare, particularly in the context of gene therapy. They share insights on leadership styles, emphasizing trust and autonomy within teams. The challenges of being a founder are explored, along with the need for inspiration and motivation in tough times. The discussion also touches on the intersection of science fiction and current scientific advancements, future trends in healthcare, and advice for aspiring professionals in the field. Chapters00:00 Introduction to Cell and Gene Therapy Innovations03:04 Exploring Vector Technology and Its Applications05:59 Brian Newsom's Journey: From Science to Business09:08 Leveraging AI and Technology in Biotech11:59 Navigating Fundraising Challenges in Biotech14:49 Strategic Partnerships and Market Positioning22:12 Building Long-Term Relationships in Healthcare23:27 Leadership Style and Team Dynamics26:00 The Challenges of Foundership28:32 Finding Inspiration and Motivation31:12 The Intersection of Science Fiction and Reality33:03 Future Trends in Healthcare35:34 Advice for Aspiring Professionals37:17 Navigating Tough Times in the Industry Guest Information:Guest's Name: Brian NewsomGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/brian-newsom/Company / Affiliation:  Carrigent https://carrigent.com/Guest's Bio: Brian Newsom is the founding CEO of the vector technology company, Carrigent, as well as the VP of Business Development for the cell therapy CDMO, Theragent. Prior to this, Brian spent six years at KBI Biopharma and almost a decade at Thermo Fisher Scientific (and legacy companies) in business development. Brian’s technical background includes posts as Head of R&D at Opexa Therapeutics and five years at Baylor College of Medicine, Center for Cell and Gene Therapy. Brian began his career in cell therapy at Aastrom Biosciences, one of the industries pioneering companies, in 1992. Brian received his degree in Microbiology from Texas Tech University and an MBA from Texas A&M University. Takeaways:Brian Newsom is the CEO of Carrigent, focusing on cell and gene therapy.Carrigent is developing a next-generation payload delivery system.The company is exploring applications in oncology, metabolic, and neurodegenerative diseases.Brian transitioned from a scientific role to business development to have a broader impact.AI is being leveraged to create efficiencies in biotech operations.Fundraising in biotech is currently challenging due to market conditions.Strategic partnerships are essential for asset development and exposure.The ultimate goal is to partner with pharma and biotech for therapeutic development.Brian's diverse background provides a unique perspective in the industry.The end users of their technology will be pharma and biotech companies. Building long-term relationships is crucial in healthcare.Leadership involves trusting your team to do their jobs.Founders often struggle to let go of their vision.Inspiration can come from various sources, including literature.Science fiction often predicts future scientific advancements.Early diagnostics are essential for effective treatment.The healthcare industry is evolving with new therapies.Resilience is key in navigating industry challenges.Patient care should be the primary motivation for professionals.The future of healthcare will focus on curing chronic diseases.

In this episode of The Healthy Enterprise, Brent Lucas, CEO of Envoy Medical, shares his journey from lawyer to medical device executive and the evolution of Envoy’s pioneering hearing technologies. He discusses the challenges of leading innovation through clinical trials, navigating the shift from private to public, and the importance of community engagement. Brent also reflects on leadership lessons from sports, family entrepreneurship, and the power of patient stories in driving impact. Chapters: 00:00 Introduction to Envoy Medical and Brent Lucas 01:01 Brent's Journey in the Hearing Loss Industry 05:03 Transforming Envoy Medical's Product Line 09:04 The Impact of Cochlear Implants on Quality of Life 13:01 Navigating Clinical Trials and Market Readiness 15:10 Transitioning from Lawyer to CEO 18:03 Leadership Challenges and Personal Management 22:07 Family Influence and Entrepreneurial Spirit 23:35 Going Public: A Strategic Decision 24:24 Navigating the Public Market: Opportunities and Challenges 27:39 Community Impact: Building Jobs and Relationships 30:10 Leadership Lessons: From Sports to Business 33:58 Overcoming Obstacles: Personal Growth and Imposter Syndrome 36:19 Innovating with Technology: The Future of Medical Devices 41:41 Marketing Strategy: Organic Growth Through Patient Stories Guest Information:Guest's Name: Brent LucasGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/brent-lucas-envoy/Company / Affiliation: Envoy Medical https://www.envoymedical.com/Guest's Bio: Brent  Lucas is CEO and Board Member of Envoy Medical, an early-stage medical device company pioneering fully implanted hearing solutions, including the Esteem® active middle ear implant and the investigational Acclaim® cochlear implant. A principled medical device executive with a legal background, Brent brings 15+ years of leadership across enterprise functions—spanning strategy, finance, compliance, stakeholder engagement, and product development. Known for his transparent and motivating leadership style, he has guided Envoy through organizational turnaround, fundraising, and global commercialization efforts. With a track record of building inspired teams, streamlining operations, and driving patient-focused innovation, Brent is dedicated to improving quality of life through breakthrough medical technologies.Takeaways:Envoy Medical is a 30-year-old startup focused on hearing loss solutions.Brent Lucas became CEO during a pivotal transformation of the company.The company specializes in fully implanted hearing devices without external components.Cochlear implants can greatly enhance the quality of life for users.Navigating clinical trials is a lengthy but necessary process for product launch.Brent transitioned from a legal background to a leadership role in a medical device company.Effective communication is crucial for leadership success.Family influence played a significant role in Brent's entrepreneurial journey.The decision to go public was strategic for the company's growth.Brent emphasizes trusting instincts in decision-making as a CEO. Going public provides liquidity options for investors and employees.Community engagement is crucial for company culture and job creation.Leadership lessons can be learned from unexpected places, like sports.Imposter syndrome is a common challenge for leaders.Innovating with technology is essential in the medical device industry.Patient demand for fully implanted devices is expected to be high.Organic marketing through patient stories can be powerful.The transition to public markets comes with both opportunities and challenges.Maintaining focus on core products is vital for success.The surgical process for the new device is outpatient and efficient.

In this episode, Stefan Lukianov, founder and CEO of Salve Therapeutics, shares his journey in biotech and the creation of a healthcare app designed to improve patient experiences. He discusses leveraging technology to lower drug development costs—especially for rare diseases—and the role of real-time health data in patient empowerment. Stefan also reflects on challenges such as fundraising, the founder-to-CEO transition, and the importance of mentorship, collaboration, and clear vision in driving innovation within the healthcare industry. Chapters:00:00 Introduction to Salve Therapeutics and Patient Empowerment02:58 The Role of Technology in Drug Development06:00 Innovative Software Solutions for Rare Diseases08:58 Patient Self-Management and Mobile Health Apps12:06 Collaboration and Mentorship in Biotech14:56 Real-Time Health Data and Patient Engagement26:23 The Journey of App Development31:01 Navigating Fundraising and Investor Relations37:17 Transitioning from Founder to CEO44:30 The Importance of Thoughtfulness in Leadership Guest Information:Guest's Name: Stefan LukianovGuest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/stefan-n-lukianov-3a6862205/Company / Affiliation:  Salve Therapeutics https://www.salvetherapeutics.com/Guest's Bio: Stefan Lukianov is an artist, author, educator, businessman, and scientist with a background in computational bioengineering. He is the founder and CEO of Salve Therapeutics, where he is dedicated to advancing patient care through innovative viral and biologic therapies powered by advanced software solutions. His work centers on patient empowerment, with a focus on leveraging real-time health data and mobile health technologies to improve self-management, independence, and access to care. Beyond his role at Salve, Stefan is a strong advocate for mentorship and collaboration in the biotech industry, aiming to foster innovation, thoughtfulness, and a more patient-centered future for healthcare.Takeaways:Stefan Lukianov is the founder and CEO of Salve Therapeutics.Salve Therapeutics focuses on patient empowerment through technology.The company aims to reduce the cost of drug development for rare diseases.Their software is designed for drug developers to streamline the process.Real-time health data is crucial for patient engagement.Collaboration and mentorship are key in the biotech field.Mobile health apps can enhance patient self-management.The goal is to make healthcare more accessible and efficient.Patient independence is a priority in healthcare innovation.Technology is transforming the way healthcare is delivered.  The app has been in development since spring 2022.It's important to attract users with the app's design and functionality.Fundraising is a complex process that requires careful planning.Transitioning from founder to CEO involves balancing vision with operational realities.Thoughtfulness in decision-making leads to better outcomes.Listening to feedback is crucial for growth as a founder and CEO.Building relationships with potential customers is key to success.The healthcare app industry is heavily regulated, making development challenging.Networking and attending events can lead to valuable connections.Having a clear vision helps in managing investor expectations.

In this episode of The Healthy Enterprise Podcast, Gautham Pasupuleti, CEO and Co-founder of Biodesign Innovation Labs, shares his journey in the medical device industry and the role of personal experiences in shaping innovation. He discusses challenges in healthcare entrepreneurship, the impact of mentorship and community, and his focus on AI and precision medicine, especially in cancer treatment, offering advice for aspiring entrepreneurs. Chapters:00:00 Introduction to Biodesign Innovation Labs02:47 Innovative Medical Devices for Critical Care05:50 AI and Precision Medicine in Cancer Care08:48 The Journey of Entrepreneurship in Healthcare12:05 Personal Experiences Shaping Innovation14:56 Building a Team and Community Engagement17:51 The Role of Mentorship and Collaboration21:07 Navigating the Healthcare Ecosystem23:56 Advice for Aspiring Innovators29:21 Journey into Medical Device Innovation32:53 Overcoming Personal Tragedy and Professional Challenges35:46 The Importance of Team Dynamics in Medical Innovation39:28 Leadership Lessons from Personal Loss44:37 Future Aspirations in Cancer Treatment and AI48:19 Advice for Aspiring Entrepreneurs Guest Information:Guest's Name: Gautham PasupuletiGuest's Title/Position: Co Founder & CEOGuest's Linkedin:https://www.linkedin.com/in/gautham-pasupuleti-84884054/Company / Affiliation: Biodesign Innovation Labs https://biodesigninnovationlabs.com/Guest's Bio: Gautham Pasupuleti is the CEO and Managing Director of Biodesign Innovation Labs, a Bangalore- and Delaware-based medical device and healthcare company developing innovative and affordable critical care solutions. He leads a multidisciplinary team focused on life-saving technologies, including the patented RespirAID device, which supported hospitals across India during COVID-19. Gautham is a recognized innovator, having received awards such as Forbes India’s Ultimate 120 Pioneers of Change, the CISCO Global Problem Solver Pandemic Response Prize, and the Best Campus Startup Innovation Award from IIT Bombay. Previously, he was a researcher at MIT Media Lab and founded CornealX, an AI-based eye care startup now integrated into Biodesign Innovation Labs. Takeaways:Biodesign Innovation Labs focuses on life-saving medical devices.Respirate is an automated solution for manual ventilation.The company started its journey in 2017 with a focus on critical care.Personal experiences can drive innovation in healthcare.Community engagement is crucial for understanding healthcare needs.Mentorship plays a significant role in entrepreneurial success.AI solutions are being developed for early cancer detection.Building a team with diverse skills is essential for success.Hands-on experience is vital for understanding real-world problems.Workshops and seminars can provide valuable insights and connections. Gautham's journey began with a desire to innovate in medical technology.He collaborated on a VR and AR device for children's eye exams.After his brother's passing, he took on significant responsibilities in their startup.The importance of innovation in medical devices cannot be overstated.Team dynamics and diverse skill sets are crucial for success.Personal experiences can drive motivation to solve meaningful problems.Leadership requires making tough decisions and trusting your instincts.Gautham learned valuable lessons from his brother's mentorship.Resilience and persistence are key traits for entrepreneurs.Networking with experienced individuals can provide valuable insights. 

In this episode of the Healthy Enterprise podcast, Kevin Harris, President of CureMetrix, shares his journey in tech and the co-founding of CureMetrix, a company using AI to improve breast cancer detection through mammography. He discusses the role of breast arterial calcifications in health, the integration of AI in radiology, and the regulatory and cultural challenges of advancing AI in healthcare. Kevin also highlights leadership, mentorship, education, and strategies for growing a successful healthcare technology company, as well as the evolving opportunities AI brings to women’s health and healthcare professionals. Chapters: 00:00 Introduction to AI in Healthcare 03:49 The Genesis of CureMetrix 09:10 Challenges in Mammography 14:58 Innovations in Breast Cancer Detection 21:10 Leadership and Team Dynamics at CureMetrix 26:19 Building a Professional Culture 27:37 Challenges in AI Adoption 31:24 Navigating Regulatory Hurdles 34:40 Sales Strategies in a Niche Market 39:02 AI's Role in Women's Healthcare 42:04 Opportunities in Healthcare Careers Guest Information:Guest's Name: Kevin HarrisGuest's Title/Position: President and co-founder Guest's Linkedin: https://www.linkedin.com/in/kevindavidharris/Company / Affiliation: CureMetrix https://curemetrix.com/Guest's Bio: Kevin Harris is the President and co-founder of CureMetrix. With over 25 years of leadership experience, Harris brings a demonstrated track record of success with particular expertise in new product ideation, implementation, market creation, and launch. As a strategic leader with deep operational expertise, Harris has led companies from inception through fundraising and mergers and acquisitions.  At CureMetrix, Harris is responsible for envisioning the AI-based products and services tied to breast cancer and breast arterial calcifications detection that are the foundation of the company’s business and are the first of their kind in the world. Takeaways:Kevin Harris has over 35 years of experience in technology.CureMetrix was founded to leverage AI in healthcare.The company focuses on improving mammography outcomes.Breast arterial calcifications can indicate serious health issues.AI can help reduce false positives in mammography.CureMetrix's software provides valuable insights to radiologists.Collaboration with data scientists is crucial for innovation.Building a strong team and mentorship is key to success.Understanding the healthcare landscape is essential for leaders.Patient outcomes can be significantly improved with AI. Building a company culture of professionalism reduces drama.AI is perceived as a tool rather than a replacement for doctors.AI operates consistently without human limitations.Regulatory challenges are significant in bringing AI to market.Sales strategies must target the right decision-makers in healthcare.Education is crucial for the adoption of AI in healthcare.AI can help radiologists focus on more critical cases.There are opportunities to automate certain healthcare tasks safely.AI can assist in pre-reading medical images to save time.The healthcare system needs to improve public education on health issues.

In this episode of The Healthy Enterprise, Anna Forsythe, founder and CEO of Oncoscope-AI, shares her journey from manually processing oncology data to creating an AI-powered platform that delivers real-time treatment insights, clinical guidelines, and research to support oncologists in an ever-evolving cancer landscape. She discusses the importance of reliable evidence in decision-making, the positive response from physicians using the free platform, and the role of systematic data reviews in building trust and efficiency. Beyond the technology, Anna reflects on her entrepreneurial path, the challenges and opportunities of leading in healthcare, and the importance of cultivating talent, mission-driven culture, and visionary leadership. The conversation concludes with her insights on business models, community impact, and the future of AI in advancing cancer care. Chapters:00:00 Introduction to Oncoscope-AI and Anna Forsythe03:04 The Need for Real-Time Oncology Data05:59 Transitioning from Manual to Automated Data Processing09:11 The Role of AI in Oncology12:13 Feedback and Response from Healthcare Professionals14:45 Data Sources and Systematic Reviews in Oncology18:02 Future Developments and Expanding Services21:53 AI in Research: Balancing Trust and Efficiency25:52 Business Model and Revenue Streams29:44 Personal Journey and Altruism in Business32:56 Challenges and Opportunities in Healthcare35:34 Leadership and Team Dynamics39:29 Visionary Leadership and Future Aspirations Guest Information:Guest's Name: Anna ForsytheGuest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/anna-forsythe-3667143/ Company / Affiliation:  Oncoscope-AI https://oncoscope-ai.com/ Guest's Bio: Anna Forsythe, PharmD, MBA, is the Founder and CEO of Oncoscope-AI, the first platform to unify real-time oncology treatment data, clinical guidelines, research, and regulatory approvals—offered free to oncology professionals worldwide and often described as “Expedia for cancer care.” With a background spanning pharmacy, health economics, and executive leadership at Novartis, Bayer, and Eisai, Anna previously co-founded Purple Squirrel Economics (acquired by Cytel in 2020), has taught health economics at Long Island University, and is a frequent industry speaker and author, with her 2022 JAMA Pediatrics article on conversion therapy ranked in the top 5% of all JAMA research outputs worldwide. Takeaways:Anna Forsythe is the founder and CEO of Oncoscope AI.Oncoscope AI provides real-time oncology treatment data and clinical guidelines.Doctors are overwhelmed with the volume of new evidence and guidelines.The platform aims to simplify access to oncology data, similar to Expedia for travel.AI is used to automate data processing but has limitations in consistency and accuracy.The platform is currently free for doctors to encourage adoption.Feedback from healthcare professionals is shaping the development of the platform.Data is sourced from publicly available databases like PubMed and clinical trials.The platform is expanding to include more cancer types and features.The response from users has been overwhelmingly positive, with over a thousand sign-ups. AI has a 0.2% error rate, necessitating careful review.A standardized database enhances research efficiency.The business model aims for profit while providing value.Personal experiences shape the desire to help others.Gathering data from doctors can lead to significant advertising revenue.The speaker is focused on launching multiple cancer treatments.Trust and transparency are crucial in AI innovation.Working with young talent is fulfilling and beneficial.Challenges in scaling the business are common in startups.Visionary leadership requires prioritization and focus.

In this episode, Sarah Bellenger, nurse veteran and entrepreneur, shares her journey creating Manage You, an app designed to fix inefficiencies in healthcare credentialing. She discusses the challenges of launching tech in a traditional industry, overcoming skepticism, and the importance of innovation and female leadership in healthcare. Sarah also reflects on funding disparities for women entrepreneurs and her vision for Manage You’s future impact on the industry. Chapters00:00 Introduction to Sarah Bellenger and Manage You03:07 The Need for Credentialing Solutions05:53 The Development Journey of Manage You08:48 Challenges in Healthcare Credentialing12:06 The App's Features and User Experience14:58 Expanding Manage You's Reach18:03 Future Developments and Scalability20:58 Entrepreneurial Insights and Challenges23:51 The Role of Women in Entrepreneurship26:47 Vision for the Future of Credentialing30:00 Conclusion and Call to Action Guest Information:Guest's Name: Sarah BellengerGuest's Title/Position: Founder & Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/sarahrbellenger/Company / Affiliation: Manage You App https://www.manageyouapp.com/Guest's Bio: Sarah Bellenger is a clinician, Army veteran, and healthcare leader with over two decades of experience in patient care, team leadership, and system-wide operations. Her career spans cardiac ICU nursing, managing anesthesia teams across the U.S. and abroad, and even supporting executive health at the White House. After earning her MBA and serving in multiple leadership roles, Sarah recognized a recurring problem: capable professionals were burning out—not from the work itself, but from the inefficiencies surrounding it. Driven by her own experiences, including losing critical credentials during frequent relocations, Sarah founded Manage You—a mobile app that helps healthcare professionals and teams centralize documents, track deadlines, and simplify renewals. Her mission is clear: to reduce administrative burdens so clinicians can focus on what matters most—caring for patients.Takeaways:Sarah Bellenger is a nurse veteran and entrepreneur.Manage You addresses the inefficiencies in the credentialing process.Credentialing is a $39 billion industry with significant waste.The app allows users to store and manage their credentials efficiently.Users receive reminders for expiring documents directly on their phones.The app is designed to be user-friendly and secure.Sarah emphasizes the importance of networking and mentorship in entrepreneurship.Women face unique challenges in securing venture capital funding.The future of credentialing may involve digital verification and AI.Sarah is committed to making healthcare credentialing more efficient.

In this episode, Dr. Harsha Rajasimha discusses his journey as a biotech entrepreneur and the founder of Jeeva Clinical Trials. He shares insights into the inefficiencies of traditional clinical trials and how AI can streamline the process, making it more efficient and accessible. The conversation also touches on the importance of inclusivity in clinical research, the role of AI agents, and the personal motivations behind his work. Dr. Rajasimha emphasizes the need for a unified platform to enhance collaboration and reduce complexity in clinical trials, ultimately aiming to improve patient outcomes. Chapters:00:00 Introduction to Jiva Clinical Trials and Harsha Rajaseema02:50 The Clinical Trial Process: Challenges and Innovations05:51 AI in Clinical Trials: Enhancing Efficiency and Security08:59 The Role of AI Agents in Clinical Research11:55 Addressing Inequities in Clinical Trials15:02 Philanthropy and Patient Advocacy in Rare Diseases18:08 The Journey of an Entrepreneur: Insights and Advice Guest Information:Guest's Name: Dr. Harsha K. RajasimhaGuest's Title/Position: Founder & Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/harsharajasimha/Company / Affiliation: Jeeva Clinical Trials https://jeevatrials.com/Guest's Bio: Dr. Harsha K. Rajasimha is a scientist, entrepreneur, and patient advocate, and the Founder & CEO of Jeeva Clinical Trials—an AI-driven platform making clinical research more efficient and accessible worldwide. He also serves as Founder and Chair of the Indo US Organization for Rare Diseases, building global collaboration to improve outcomes for patients with rare conditions. Motivated by personal loss, Harsha has dedicated his 20-year career in precision medicine and biotech to advancing rare disease research, patient advocacy, and the use of technology to accelerate clinical trials.Takeaways:Dr. Harsha Rajasimha is the founder of Jeeva Clinical Trials.Clinical trials typically take 8-10 years to complete.AI can significantly reduce the time and cost of clinical trials.The current clinical trial infrastructure is complex and fragmented.Jeeva aims to unify the clinical trial process with a single platform.AI agents will automate repetitive tasks in clinical trials.Inclusivity in clinical trials is crucial for diverse patient representation.Philanthropy plays a key role in Dr. Rajasimha's mission.The platform supports over 100 languages for global accessibility.Community support is essential for entrepreneurial success.

In this episode, Bill Wittmeyer discusses his journey as the CEO of Maggie's Breath, a company focused on using breath analysis for early detection of breast cancer. He shares insights into the technology behind breath analysis, the importance of early detection, and the challenges faced in the healthcare industry. Bill also reflects on the personal impact of breast cancer in his life and the future plans for Maggie's Breath, including clinical trials and funding efforts. Chapters: 00:00 Introduction to Bill Wittmeyer and Maggie's Breath 03:04 The Journey to Breath Analysis Technology 05:55 The Importance of Early Detection in Breast Cancer 08:56 Innovative Screening Methods and Their Implications 11:49 The Role of Metabolic Compounds in Disease Detection 15:05 Challenges in Implementing New Screening Technologies 18:01 Mobile Screening Solutions for Breast Cancer 20:59 Future Directions and Global Health Implications 26:55 Clinical Trials and Market Opportunities 30:02 Innovative Screening Technologies 34:04 Navigating Regulatory Challenges 36:10 The Journey of a Startup Founder 41:45 Personal Loss and Legacy 49:30 Fundraising and Community Engagement Guest Information:Guest's Name: Bill WittmeyerGuest's Title/Position: Founder & Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/bill-wittmeyer-b0628a/Company / Affiliation: Maggie's Breath https://www.maggiesbreath.com/ Guest's Bio: Bill Wittmeyer is the Founder and CEO of Maggie’s Breath (formerly Pulmostics Limited) where he applies advanced detection technologies—such as high-speed gas chromatography—to protect human health and the environment. Maggie’s Breath was renamed in honour of Bill’s late wife, Maggie, who lost her battle with breast cancer while working to advance life-saving diagnostics. Her vision lives on through the company’s mission: to create a revolutionary, non-invasive breath-based screening tool that can detect disease early and save lives. Bill’s leadership spans innovations in healthcare, environmental monitoring, and public safety, all driven by a commitment to turning personal loss into global impact for a healthier, more sustainable world.Takeaways: -Bill Wittmeyer is the CEO of Maggie's Breath, focused on breath analysis for breast cancer detection. -Maggie's Breath aims to provide a non-invasive screening tool for breast cancer. -The technology can analyze breath samples in just one minute. -Breast cancer is increasingly affecting younger women, necessitating early detection methods. -Current mammogram practices may not be effective for women with dense breast tissue. -Breath analysis could complement existing mammogram technologies. -The goal is to provide diagnostically actionable information at the point of care. -Maggie's Breath was named in honor of Bill's late wife, who passed away from breast cancer. -The company is seeking funding and partnerships to conduct clinical trials in Mexico. -Bill emphasizes the importance of early detection in improving survival rates and reducing treatment costs.